Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 228580 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 238798 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 309332 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 313776 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 331348 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 343251 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 351293 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 368588 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 376083 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 377893 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 377957 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 388994 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 393375 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 409223 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 414403 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 418480 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 422112 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 434384 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 436157 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 467615 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 493859 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 514500 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 541676 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 553574 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 579263 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 618651 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 3555 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 26932 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 38377 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 38409 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 38598 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 39032 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 39107 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 39955 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 40556 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 41700 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 41785 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 45643 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 46919 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 49446 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 51081 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 54684 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 56319 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 57270 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 58793 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 59088 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 59102 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 60246 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 66314 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 74018 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 81802 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | Peak area normalized | female | Pre-diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 27706 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 30669 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 37364 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 40193 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 42944 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 43326 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 47227 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 49040 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 51252 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 52232 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 53376 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 55948 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 56049 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 59446 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 65981 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 66600 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 67509 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 73926 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 79166 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 84211 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 84275 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 85402 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 95813 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 106258 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | Peak area normalized | female | Pre-diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | Peak area normalized | male | Diabetic | no neuropathy |